EVIAGENICS sells its Vanillin technology
EVIAGENICS concluded in June 2015 the sale of its yeast based Vanillin technology (and related patents) to a large industrial player. The terms and conditions of this transaction are confidential. Algaia is now concentrating its Biotech R&D efforts to specific...
EVIAGENICS raises 2.5m€ additional funding for its strategy
EVIAGENICS raises 2.5m€ additional funding from its current investors to deploy its strategy related to seaweed extracts .
EVIAGENICS starts an agreement with GELYMAR
GELYMAR enters into a commercial and development agreement with EVIAGENICS in Europe regarding seaweed extracts. Andres Hohlberg (Gelymar CEO) and Fabrice Bohin (EVIAGENICS CEO) January 22nd 2015: GELYMAR, a Chilean company currently being one of the top 4 global...